The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data

BACKGROUND: Spurred by success in several foci, onchocerciasis control policy in Africa has shifted from morbidity control to elimination of infection. Clinical trials have demonstrated that moxidectin is substantially more efficacious than ivermectin in effecting sustained reductions in skin microf...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Hugo C, Walker, Martin, Attah, Simon K, Opoku, Nicholas O, Awadzi, Kwablah, Kuesel, Annette C, Basáñez, María-Gloria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381491/
https://www.ncbi.nlm.nih.gov/pubmed/25889256
http://dx.doi.org/10.1186/s13071-015-0779-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381491/
https://www.ncbi.nlm.nih.gov/pubmed/25889256
http://dx.doi.org/10.1186/s13071-015-0779-4

Ejemplares similares